Postprandial versus Preprandial Blood Glucose Monitoring in Women with Gestational Diabetes Mellitus Requiring Insulin Therapy
Margarita de Veciana, M.D., Carol A. Major, M.D., Mark A. Morgan, M.D., Tamerou Asrat, M.D., Julianne S. Toohey, M.D., Jean M. Lien, M.D., and Arthur T. Evans, M.D.
Background The fetuses of women with gestational diabetes mellitusare at risk for macrosomia and its attendant complications.The best method of achieving euglycemia in these women and reducingmorbidity in their infants is not known. We compared the efficacyof postprandial and preprandial monitoring in achieving glycemiccontrol in women with gestational diabetes.
Methods We studied 66 women with gestational diabetes mellituswho required insulin therapy at 30 weeks of gestation or earlier.The women were randomly assigned to have their diabetes managedaccording to the results of preprandial monitoring or postprandialmonitoring (one hour after meals) of blood glucose concentrations.Both groups were also monitored with fasting blood glucose measurements.The goal of insulin therapy was a preprandial value of 60 to105 mg per deciliter (3.3 to 5.9 mmol per liter) or a postprandialvalue of less than 140 mg per deciliter (7.8 mmol per liter).Obstetrical data and information on neonatal outcomes were collected.
Results The prepregnancy weight, weight gain during pregnancy,gestational age at the diagnosis of diabetes and at delivery,degree of compliance with therapy, and degree of achievementof target blood glucose concentrations were similar in the twogroups. The mean (±SD) change in the glycosylated hemoglobinvalue was greater in the group in which postprandial measure-mentswere used (-3.0±2.2 percent vs. -0.6±1.6 percent,P<0.001) and the infants' birth weight was lower (3469±668vs. 3848±434 g, P = 0.01). Similarly, the infants bornto the women in the postprandial-monitoring group had a lowerrate of neonatal hypoglycemia (3 percent vs. 21 percent, P =0.05), were less often large for gestational age (12 percentvs. 42 percent, P = 0.01) and were less often delivered by cesareansection because of cephalopelvic disproportion (12 percent vs.36 percent, P = 0.04) than those in the preprandial-monitoringgroup.
Conclusions Adjustment of insulin therapy in women with gestationaldiabetes according to the results of postprandial, rather thanpreprandial, blood glucose values improves glycemic controland decreases the risk of neonatal hypoglycemia, macrosomia,and cesarean delivery.
Source Information
From the Department of Obstetrics and Gynecology, Division of MaternalFetal Medicine, Eastern Virginia Medical School, Norfolk (M.V., A.T.E.); the University of California, Irvine (C.A.M., J.S.T., J.M.L.); the University of Pennsylvania School of Medicine, Philadelphia (M.A.M.); and Long Beach Memorial Medical Center, Long Beach, Calif. (T.A.).
Address reprint requests to Dr. de Veciana at the Department of Obstetrics and Gynecology, Division of MaternalFetal Medicine, Eastern Virginia Medical School, 825 Fairfax Ave., Suite 310, Norfolk, VA 23507.
Jovanovic, L.
(2009). Using Meal-Based Self-Monitoring Blood Glucose (SMBG) Data to Guide Dietary Recommendations in Patients With Diabetes. The Diabetes Educator
35: 1023-1030
[Abstract][Full Text]
Hyer, S. L, Balani, J., Johnson, A., Shehata, H.
(2009). Metformin treatment for gestational diabetes. British Journal of Diabetes & Vascular Disease
9: 220-225
[Abstract]
Fraser, R.
(2009). Drug use in gestational diabetes. British Journal of Diabetes & Vascular Disease
9: 33-35
[Abstract]
Murphy, H. R, Rayman, G., Lewis, K., Kelly, S., Johal, B., Duffield, K., Fowler, D., Campbell, P. J, Temple, R. C
(2008). Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ
337: a1680-a1680
[Abstract][Full Text]
Coustan, D. R.
(2008). A 40-Year-Old Woman With Diabetes Contemplating Pregnancy After Gastric Bypass Surgery. JAMA
299: 2550-2557
[Abstract][Full Text]
Hillier, T. A., Vesco, K. K., Pedula, K. L., Beil, T. L., Whitlock, E. P., Pettitt, D. J.
(2008). Screening for Gestational Diabetes Mellitus: A Systematic Review for the U.S. Preventive Services Task Force. ANN INTERN MED
148: 766-775
[Abstract][Full Text]
Kitzmiller, J. L., Block, J. M., Brown, F. M., Catalano, P. M., Conway, D. L., Coustan, D. R., Gunderson, E. P., Herman, W. H., Hoffman, L. D., Inturrisi, M., Jovanovic, L. B., Kjos, S. I., Knopp, R. H., Montoro, M. N., Ogata, E. S., Paramsothy, P., Reader, D. M., Rosenn, B. M., Thomas, A. M., Kirkman, M. S.
(2008). Managing Preexisting Diabetes for Pregnancy: Summary of evidence and consensus recommendations for care. Diabetes Care
31: 1060-1079
[Full Text]
Milicevic, Z., Raz, I., Beattie, S. D., Campaigne, B. N., Sarwat, S., Gromniak, E., Kowalska, I., Galic, E., Tan, M., Hanefeld, M.
(2008). Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia. Diabetes Care
31: S155-S160
[Abstract][Full Text]
Peter, R., Rees, A.
(2008). Review: Postprandial glycaemia and cardiovascular risk. British Journal of Diabetes & Vascular Disease
8: 8-14
[Abstract]
Jovanovic, L.
(2007). Point: Oral Hypoglycemic Agents Should Not Be Used to Treat Diabetic Pregnant Women. Diabetes Care
30: 2976-2979
[Full Text]
Hod, M., Yogev, Y.
(2007). Goals of Metabolic Management of Gestational Diabetes: Is it all about the sugar?. Diabetes Care
30: S180-S187
[Full Text]
Reader, D. M.
(2007). Medical Nutrition Therapy and Lifestyle Interventions. Diabetes Care
30: S188-S193
[Abstract][Full Text]
Jovanovic, L., Pettitt, D. J.
(2007). Treatment With Insulin and Its Analogs in Pregnancies Complicated by Diabetes. Diabetes Care
30: S220-S224
[Full Text]
Perkins, J. M., Dunn, J. P., Jagasia, S. M.
(2007). Perspectives in Gestational Diabetes Mellitus: A Review of Screening, Diagnosis, and Treatment. Clin. Diabetes
25: 57-62
[Abstract][Full Text]
Mathiesen, E. R., Kinsley, B., Amiel, S. A., Heller, S., McCance, D., Duran, S., Bellaire, S., Raben, A., on behalf of the Insulin Aspart Pregnancy Study Gr,
(2007). Maternal Glycemic Control and Hypoglycemia in Type 1 Diabetic Pregnancy: A randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care
30: 771-776
[Abstract][Full Text]
Di Cianni, G., Volpe, L., Ghio, A., Lencioni, C., Cuccuru, I., Benzi, L., Del Prato, S.
(2007). Maternal Metabolic Control and Perinatal Outcome in Women With Gestational Diabetes Mellitus Treated With Lispro or Aspart Insulin: Comparison with regular insulin. Diabetes Care
30: e11-e11
[Full Text]
Trujillo, A. L.
(2007). Insulin Analogs and Pregnancy. Diabetes Spectr.
20: 94-101
[Abstract][Full Text]
Lucotti, P., Setola, E., Monti, L. D., Galluccio, E., Costa, S., Sandoli, E. P., Fermo, I., Rabaiotti, G., Gatti, R., Piatti, P.
(2006). Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am. J. Physiol. Endocrinol. Metab.
291: E906-E912
[Abstract][Full Text]
Shim, W. S., Kim, S. K., Kim, H. J., Kang, E. S., Ahn, C. W., Lim, S. K., Lee, H. C., Cha, B. S.
(2006). Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes.. Eur J Endocrinol
155: 615-622
[Abstract][Full Text]
Saudek, C. D., Derr, R. L., Kalyani, R. R.
(2006). Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1c. JAMA
295: 1688-1697
[Abstract][Full Text]
Zisser, H., Jovanovic, L., Thorsell, A., Kupperman, A., Taylor, L. J, Ospina, P., Hod, M.
(2006). The Fidgety Fetus Hypothesis: Fetal activity is an additional variable in determining birth weight of offspring of women with diabetes. Diabetes Care
29: 63-67
[Abstract][Full Text]
Heine, R. J., Van Gaal, L. F., Johns, D., Mihm, M. J., Widel, M. H., Brodows, R. G., for the GWAA Study Group*,
(2005). Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes: A Randomized Trial. ANN INTERN MED
143: 559-569
[Abstract][Full Text]
Setji, T. L., Brown, A. J., Feinglos, M. N.
(2005). Gestational Diabetes Mellitus. Clin. Diabetes
23: 17-24
[Abstract][Full Text]
Parretti, E., Carignani, L., Cioni, R., Bartoli, E., Borri, P., La Torre, P., Mecacci, F., Martini, E., Scarselli, G., Mello, G.
(2003). Sonographic Evaluation of Fetal Growth and Body Composition in Women With Different Degrees of Normal Glucose Metabolism. Diabetes Care
26: 2741-2748
[Abstract][Full Text]
Bloomgarden, Z. T.
(2003). Diabetes Issues in Women and Children: Polycystic ovary syndrome. Diabetes Care
26: 2457-2463
[Full Text]
Boskovic, R., Feig, D. S., Derewlany, L., Knie, B., Portnoi, G., Koren, G.
(2003). Transfer of Insulin Lispro Across the Human Placenta: In vitro perfusion studies. Diabetes Care
26: 1390-1394
[Abstract][Full Text]
Buse, J. B.
(2003). Should Postprandial Glucose Be Routinely Measured and Treated to a Particular Target? No!. Diabetes Care
26: 1615-1618
[Full Text]
Jovanovic, L.
(2003). Point: Yes, It Is Necessary to Rely Entirely on Glycemic Values for the Insulin Treatment of All Gestational Diabetic Women. Diabetes Care
26: 946-947
[Full Text]
Buchanan, T. A., Kjos, S. L.
(2003). Counterpoint: Glucose Monitoring in Gestational Diabetes: Lots of heat, not much light. Diabetes Care
26: 948-949
[Full Text]
Pettitt, D. J., Ospina, P., Kolaczynski, J. W., Jovanovic, L.
(2003). Comparison of an Insulin Analog, Insulin Aspart, and Regular Human Insulin With No Insulin in Gestational Diabetes Mellitus. Diabetes Care
26: 183-186
[Abstract][Full Text]
Schaefer-Graf, U. M., Kjos, S. L., Kilavuz, O., Plagemann, A., Brauer, M., Dudenhausen, J. W., Vetter, K.
(2003). Determinants of Fetal Growth at Different Periods of Pregnancies Complicated by Gestational Diabetes Mellitus or Impaired Glucose Tolerance. Diabetes Care
26: 193-198
[Abstract][Full Text]
Bloomgarden, Z. T.
(2003). Cardiovascular Disease and Diabetes. Diabetes Care
26: 230-237
[Full Text]
Salardi, S., Zucchini, S., Santoni, R., Ragni, L., Gualandi, S., Cicognani, A., Cacciari, E.
(2002). The Glucose Area Under the Profiles Obtained With Continuous Glucose Monitoring System Relationships With HbAlc in Pediatric Type 1 Diabetic Patients. Diabetes Care
25: 1840-1844
[Abstract][Full Text]
Cowett, R. M.
(2002). The Infant of the Diabetic Mother. NeoReviews
3: e173-189
[Full Text]
Mikhail, N., Beckman, J. A., Creager, M. A., Libby, P.
(2002). Postprandial Hyperglycemia and Risk of Atherosclerosis. JAMA
288: 955-955
[Full Text]
Knopp, R. H.
(2002). John B. O'Sullivan: A Pioneer in the Study of Gestational Diabetes. Diabetes Care
25: 943-944
[Full Text]
Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., Parrott, M.
(2002). Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Clin. Chem.
48: 436-472
[Abstract][Full Text]
Franz, M. J., Bantle, J. P., Beebe, C. A., Brunzell, J. D., Chiasson, J.-L., Garg, A., Holzmeister, L. A., Hoogwerf, B., Mayer-Davis, E., Mooradian, A. D., Purnell, J. Q., Wheeler, M.
(2002). Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications. Diabetes Care
25: 148-198
[Full Text]
Simmons, D., Thompson, C. F., Conroy, C., Scott, D. J.
(2001). Use of Insulin Pumps in Pregnancies Complicated by Type 2 Diabetes and Gestational Diabetes in a Multiethnic Community. Diabetes Care
24: 2078-2082
[Abstract][Full Text]
Jovanovic, L., Pettitt, D. J.
(2001). Gestational Diabetes Mellitus. JAMA
286: 2516-2518
[Full Text]
Jovanovic, L.
(2001). What Is So Bad About a Big Baby?. Diabetes Care
24: 1317-1318
[Full Text]
Parretti, E., Mecacci, F., Papini, M., Cioni, R., Carignani, L., Mignosa, M., La Torre, P., Mello, G.
(2001). Third-Trimester Maternal Glucose Levels From Diurnal Profiles in Nondiabetic Pregnancies: Correlation with sonographic parameters of fetal growth. Diabetes Care
24: 1319-1323
[Abstract][Full Text]
Ray, J.G., Vermeulen, M.J., Shapiro, J.L., Kenshole, A.B.
(2001). Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study. QJM
94: 347-356
[Abstract][Full Text]
American Diabetes Association,
(2001). Postprandial Blood Glucose. Diabetes Care
24: 775-778
[Full Text]
American Diabetes Association,
(2001). How Do We Diagnose Diabetes and Measure Blood Glucose Control?: View 2: (Measuring Control) Consensus Statement: Postprandial Blood Glucose. Diabetes Spectr.
14: 71-74
[Full Text]
Egeland, G. M, Skjærven, R., Irgens, L. M
(2000). Birth characteristics of women who develop gestational diabetes: population based study. BMJ
321: 546-547
[Full Text]
Kjos, S. L., Buchanan, T. A.
(1999). Gestational Diabetes Mellitus. NEJM
341: 1749-1756
[Full Text]
Nachum, Z., Ben-Shlomo, I., Weiner, E., Shalev, E.
(1999). Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial. BMJ
319: 1223-1227
[Abstract][Full Text]
Solomon, C. G., Willett, W. C., Carey, V. J., Rich-Edwards, J., Hunter, D. J., Colditz, G. A., Stampfer, M. J., Speizer, F. E., Spiegelman, D., Manson, J. E.
(1997). A Prospective Study of Pregravid Determinants of Gestational Diabetes Mellitus. JAMA
278: 1078-1083
[Abstract]
Bargiota, A, Corrall, R J M
(1997). Monitoring blood glucose in gestational diabetes. BMJ
314: 3-3
[Full Text]
Bansal, R. K., Ecker, J. L., Laros, R. K., Miles, J.M., Coppack, S.W., Buchanan, T. A., Kjos, S. L., Montoro, M. N., de Veciana, M., Morgan, M. A., Major, C. A.
(1996). Blood Glucose Monitoring in Gestational Diabetes Mellitus. NEJM
334: 598-599
[Full Text]
(1995). IMPROVING PREGNANCY OUTCOMES IN GESTATIONAL DIABETICS. JWatch General
1995: 4-4
[Full Text]
Dornhorst, A., Girling, J. C.
(1995). Management of Gestational Diabetes Mellitus. NEJM
333: 1281-1283
[Full Text]